CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up

International Journal of Cardiology
Marianne HartfordKenneth Caidahl

Abstract

The objectives of this study were to examine the time course of the inflammatory response in acute coronary syndromes (ACS) and to assess the markers of inflammation and their relation to disease severity. We prospectively studied 134 patients with ACS who survived for at least 30 months. The patients were divided into four groups: acute myocardial infarction (MI) with (n=54) or without (n=46) ST-segment elevation and unstable angina with (n=14) or without (n=20) increased risk. Plasma levels of C-reactive protein (CRP), interleukin-6 (IL-6), secretory phospholipase A2 group IIA (sPLA2-IIA), and intercellular adhesion molecule-1 (ICAM-1) were measured on days 1 and 4 and after 3 and 30 months. The highest levels of CRP and sPLA2-IIA were seen on day 4 but for IL-6 on day 1. These three markers, but not ICAM-1, were significantly related to disease severity, CKMB, and ejection fraction. Patients in Killip class II-IV had higher levels than those in Killip class I. The individual acute-phase responses correlated with marker levels at 3 and 30 months. ICAM-1 correlated with the development of congestive heart failure. In ACS there seems to be an individual predisposition to inflammatory response. Plasma IL-6 is the first marker to...Continue Reading

References

Aug 18, 1994·The New England Journal of Medicine·G LiuzzoA Maseri
Jan 1, 1996·Medicinal Research Reviews·B E Barton
Aug 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·M F NagehA L Beaudet
Mar 25, 1999·Clinica Chimica Acta; International Journal of Clinical Chemistry·R PudilM Drahosová
Jul 2, 1999·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·L M BiasucciG Liuzzo
Apr 13, 2000·Journal of Internal Medicine·P Libby
Oct 19, 2000·The New England Journal of Medicine·D J Rader
May 23, 2001·International Immunopharmacology·R NijmeijerC E Hack
Aug 18, 2001·Circulation Research·E Hurt-CamejoP Kovanen
Oct 12, 2001·European Journal of Heart Failure·S AdamopoulosD T Kremastinos
Dec 18, 2001·Cardiovascular Research·Remco NijmeijerHans W M Niessen
Apr 16, 2002·Journal of Internal Medicine·O WiklundJ Oscarsson
Jul 5, 2002·The New England Journal of Medicine·Antonino BuffonAttilio Maseri
Aug 24, 2002·Coronary Artery Disease·Sarah A HopeNicholas D Balazs
Oct 18, 2002·European Journal of Internal Medicine·Hans Ablij, Arend Meinders
Mar 26, 2003·Journal of the American College of Cardiology·Stefan K JamesUNKNOWN GUSTO-IV-ACS Investigators
Jun 11, 2003·American Heart Journal·Giuseppe BertonPaolo Palatini
Aug 19, 2003·European Journal of Heart Failure·Wei-Hsian YinMason Shing Young
Oct 18, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Nejma AmezianeDominique de Prost
Nov 13, 2003·Atherosclerosis·Stefan BlankenbergLaurence Tiret
Apr 15, 2005·The New England Journal of Medicine·Beth Cohen, David Singh

❮ Previous
Next ❯

Citations

Oct 13, 2011·Cardiovascular Drugs and Therapy·Robert S RosensonColin Hislop
May 21, 2008·Current Atherosclerosis Reports·Ann-Cathrine Jönsson-RylanderEva Hurt-Camejo
Jul 18, 2012·European Heart Journal·Robert S Rosenson, Eva Hurt-Camejo
Jul 30, 2011·Future Cardiology·Jonathan W Waks, Benjamin M Scirica
May 3, 2011·Nature Reviews. Drug Discovery·Israel F Charo, Rebecca Taub
Jan 15, 2014·Critical Reviews in Clinical Laboratory Sciences·Giuseppe Lippi, Gianfranco Cervellin
Sep 3, 2010·Expert Opinion on Investigational Drugs·Robert S RosensonColin Hislop
Feb 27, 2010·Scandinavian Cardiovascular Journal : SCJ·Ole EschenErik Berg Schmidt
Jul 3, 2009·Atherosclerosis·Gerd Schmitz, Katharina Ruebsaamen
Aug 31, 2007·International Journal of Cardiology·Virtudes VilaEdelmiro Reganon
Apr 6, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Patrizia FerroniStefania Basili
Apr 16, 2010·Clinical Cardiology·Steen HustedChristopher P Cannon
Mar 10, 2015·Brain, Behavior, and Immunity·Isabelle Granville SmithUté Vollmer-Conna
Feb 7, 2012·International Journal of Cardiology·Kenneth CaidahlJohan Frostegård
Feb 12, 2008·Journal of the American College of Cardiology·Torbjørn OmlandKenneth Caidahl
Apr 8, 2014·Results in Immunology·Vibeke N RitschelGeir Ø Andersen
Feb 15, 2015·European Heart Journal. Acute Cardiovascular Care·Ignacio M SeropianAntonio Abbate
Feb 17, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Ziad MallatS Matthijs Boekholdt
Sep 5, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Philippa J Talmud, Michael V Holmes
Jun 1, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nara SzostaczukCatalina Picó
Jul 1, 2020·International Journal of Molecular Sciences·Eva Knuplez, Gunther Marsche
Jan 30, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Sally PicciottoAnnette Peters
Nov 30, 2019·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·D O C LinoG B Silva Junior
Oct 2, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ryung Rae KimW Bret Church
Nov 21, 2018·JACC. Basic to Translational Science·Robert Roberts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.